Trial Profile
GTx-024 as a Treatment for Stress Urinary Incontinence in Women: A Proof of Concept Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enobosarm (Primary)
- Indications Stress incontinence
- Focus Proof of concept; Therapeutic Use
- Sponsors GTx
- 24 Sep 2018 Status changed from active, no longer recruiting to completed.
- 04 Jun 2018 Planned End Date changed from 1 Jul 2018 to 1 Sep 2018.
- 04 Jun 2018 Planned primary completion date changed from 1 May 2018 to 1 Sep 2018.